Synthesis and separation of the clarithromycin A(E)-9-O-methyl oxime

Yi Jiao Nie, Ling Li Li, Cong Liu, Rong Ji Dai, Li Quan Sun, Guo Wei Yao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

To control the commercial production of clarithromycin, clarithromycin A(E)9-O-methyl oxime was synthesized using clarithromycin A oxime as the raw material by three steps: protection of 2'-OH and 4″-OH with TMS, methylation and de-protection of TMS. The structure was identified by 1H NMR, 13C NMR and HPLC analysis was conducted. Experimental results show that the reactions are greatly affected by catalyst, solvent and pH value. The parameters of HPLC are as follows. The mobile phase is ACN/KH 2PO 4 aqueous solution (V/V=45/55), wavelength is 210 nm, temperature is 30°C and the velocity of flow is 1.0 mL/min. This synthesized compound is of benefit to control the commercial production of clarithromycin.

Original languageEnglish
Pages (from-to)102-105
Number of pages4
JournalBeijing Ligong Daxue Xuebao/Transaction of Beijing Institute of Technology
Volume32
Issue number1
Publication statusPublished - Jan 2012

Keywords

  • Clarithromycin A
  • Clarithromycin A 9 oxime
  • Clarithromycin A(E)-9-O-methyl oxime

Fingerprint

Dive into the research topics of 'Synthesis and separation of the clarithromycin A(E)-9-O-methyl oxime'. Together they form a unique fingerprint.

Cite this